Manutara Ventures
Miraflores 222, piso 28, Santiago, Region Metropolitana, 7710112, Chile
Overview
Manutara Ventures was created to become the most relevant actor in the Venture Capital industry in Chile and Latin America, based on a convergence model with a global seal and a strong emphasis on the construction of successful outlets.
- Total investments
- 4
- Lead investments
- 3
- Investments · 12mo
- 0
- Active investors
- 3
Investment portfolio
- Levannta
Led · Equity · Dec 2023
Levannta is a Chilean fintech founded in 2022 that integrates with companies' financial and subscription data to provide upfront working capital against future recurring‑revenue contracts. Its core product allows businesses operating on subscription or recurring models to obtain the value of the next 12–24 months of contracts to fund growth. The startup has grown its customer base fivefold over the past year, from about 50 to 250 clients. Levannta plans to use new capital to strengthen originations, marketing and sales teams and to support international expansion after consolidating the local market. The company participated in a Manutara online scaling program and has backing from Option. Recent financing activity includes both equity and debt to underpin its lending proposition and growth plans.
- Fracción
Led · Equity · Dec 2023
Fracción was founded in 2018 by Javier Vega and José Manuel Moller to sell fractioned medications, later evolving into a digital pharmacy with some physical branches. Its core offering is selling medications in fractional doses to let customers "buy and pay the right amount," complemented by physical 30 m2 modules installed near clinics. The company runs the social initiative Comunas Sin Farmacias (launched 2020), aiming to reach 50 communes by 2026; this semester it completed the first 10 (six operating, four in final stages). Fracción works with Tecno Fast to deploy modular pharmacy units and has measured social impact with universities, finding a high social return (reported as 4 pesos staying in the community per peso invested). Operationally, the startup reports more than 35,000 customers over six years and closed 2023 with about 2 billion pesos in revenue. Future plans include developing a user app, expanding into veterinary, dental, cosmetics and natural products, launching a monthly medication-delivery subscription, entering complementary insurance, and creating a foundation to scale Comunas Sin Farmacias. Fracción is an impact start-up dedicated to the fractionation of medicines, allowing customers to purchase medications in specific doses at fair prices. It operates as a 100% online platform and has partnered with independent pharmacies to distribute fractionated doses. The platform enables smaller, dose-specific purchases through its pharmacy partnerships. In its most recent financing, Manutara Ventures, through its Founders Fund, led a US$5 million investment that closed on 30 November. The Founders Fund is Manutara’s second fund and focuses on blockchain technologies, SaaS, biotech, healthtech, wellness, and foodtech. Carey represented Manutara Ventures in the transaction while Prieto Abogados acted as advisor to Fracción.
- Xepelin
Participated · Equity · Oct 2020
Xepelin offers an end-to-end digital platform that gives SMEs fast access to working capital, invoice financing and other embedded financial products. Since its founding, the company has served more than 70,000 businesses and currently generates roughly US$100 million in annual revenue. Management is focusing on Mexico, where it is pursuing a Sofipo license to broaden its product set and position itself as the “Nubank for SMEs” by 2026. Xepelin employs about 500 people and recently strengthened its tech leadership by hiring former Fintual CTO Martín Ugarte as vice-president of engineering. The company was previously valued at about US$720 million after its 2022 Series B, but that figure has reset to around US$400 million in the latest round. Historically, Xepelin has combined equity and significant debt facilities, including a US$30 million equity plus US$200 million credit Series A in 2021 and a US$140 million debt line from Goldman Sachs. Founders include Sebastián Kreis, Nicolás de Camino, Diego Contreras, Felipe Puntarelli, Carlos Veloso and Guillermo Molina. The firm remains one of Chile’s most heavily funded tech startups and aims to scale regionally toward unicorn status.
- Ipsum
Led · Equity · Jan 2018
Ipsum offers a web and mobile collaborative platform, Proplanner, designed to improve coordination and planning among the different actors in construction projects. Founded in 2014 and led by CEO Franco Giaquinto, the company operates across Latin America with presence in Peru, Argentina, Chile and Paraguay and customers such as Ingevec, Echeverría Izquierdo, Flesan, Graña y Montero and Caputo. By the end of 2017 Ipsum grew from three initial clients to a portfolio of more than thirty clients, commercializing Proplanner in five countries and running on 80 construction sites in parallel. The company was recognized by CB Insights as one of 100 platforms revolutionizing the construction industry globally. Ipsum plans to use new funding to continue internationalization and to introduce improvements to its software. Prior investors include Telefónica Open Future and Wayra, which invested in 2016.